Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Krystal Biotech, Inc. | krys-ex312_6.htm |
| EX-31.1 - EX-31.1 - Krystal Biotech, Inc. | krys-ex311_7.htm |
| 10-Q - 10-Q - Krystal Biotech, Inc. | krys-10q_20200630.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF ACCOUNTING OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Krish S. Krishnan, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
1. |
the Quarterly Report on Form 10-Q for the three months ended June 30, 2020, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
2. |
information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Krystal Biotech, Inc. |
|
Date: August 7, 2020 |
|
By: |
|
/s/ Krish S. Krishnan |
|
|
|
|
|
Krish S. Krishnan |
|
|
|
|
|
President and Chief Executive Officer |
I, Kathryn A. Romano, Chief Accounting Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
1. |
the Quarterly Report on Form 10-Q for the three months ended June 30, 2020, (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
2. |
information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Krystal Biotech, Inc. |
|
Date: August 7, 2020 |
|
By: |
|
/s/ Kathryn A. Romano |
|
|
|
|
|
Kathryn A. Romano |
|
|
|
|
|
Chief Accounting Officer |